CardioGraft-MC® Decellularized Pulmonary Patch Graft

Download the files in the language of your choice
Instructions for Use
Product Specifications

CardioGraft-MC®

CardioGraft-MC® Decellularized Pulmonary Patch Graft
Decellularized human pulmonary patch used for right side cardiac repair and reconstruction
  • Clinical effectiveness – lower potential for reoperation or intervention1,2
  • Patented, validated decellularization and disinfection process that removes ≥99% of donor DNA3
  • Resists calcification and stenosis1,2
  • Allografts most closely resemble native tissue, making them compliant, flexible and easy to handle
  • Potentially reduces operating room time and cost by reducing the rate of serious adverse events and reoperations4
​
 
Clinical Application
  • Repair of the right ventricular outflow tract for Tetralogy of Fallot
  • Truncus Arteriosis
  • Hypoplastic Left Heart Syndrome
  • Transposition of the Great Arteries
  • Pulmonary Stenosis/Atresia
Frozen Description Sizing
DPPGK Thick (Trunk) W = 2.5 - 5 cm; L = 3 - 8 cm
DPPGN Thin (Branch) W = 2.5 - 5 cm; L = 3 - 8 cm
References
  1. Lofland GK, et al. Initial pediatric cardiac experience with decellularized allograft patches. Ann of Thoracic Surg, 2012;93:968-71
  2. Hopkins RA, et al. Pulmonary Arterioplasty With Decellularized Allogeneic Patches. Ann of Thoracic Surg, Vol. 97, Issue 4, April 2014, Pages 1407-1412
  3. LifeNet Health data on file: PQ-07-078
  4. CardioGraft-MC (also known as Matracell®) Decellularized Cardiac Patch Allograft Cost-Effectiveness Analysis
  5. Musculoskeletal Clinical Regulatory Advisors, June 2014